These results suggest that YKL-40 is a promising pro-inflammatory marker in in vitro cultured pro-inflammatory macrophages, but is less suitable for monitoring in vivo effect of treatment with steroids on YKL-40 in serum and sputum of COPD patients. This evidence concerns the gene CHI3L1 and chronic obstructive pulmonary disease.